New knee injection may beat PRP for arthritis pain
NCT ID NCT06932614
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times
Summary
This study tests whether a new, more concentrated growth factor injection (SRF) works better than standard PRP for knee osteoarthritis. About 90 adults aged 20-80 with mild to moderate knee arthritis will receive one of the two injections. The goal is to see if SRF provides greater pain relief and improved knee function over 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
No. 325, Sec. 2, Chenggong Rd., Neihu Dist.
RECRUITINGTaipei, 114, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.